H. Lundbeck A/S Stock Forecast, Price & News

-0.43 (-1.37 %)
(As of 06/17/2021 03:22 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume1,868 shs
Average Volume2,883 shs
Market Capitalization$6.11 billion
P/E Ratio17.43
Dividend Yield0.87%
30 days | 90 days | 365 days | Advanced Chart
Receive HLUYY News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

H. Lundbeck A/S logo

About H. Lundbeck A/S

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy. The company was founded in 1915 and is headquartered in Valby, Denmark.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.44 out of 5 stars

Medical Sector

680th out of 2,102 stocks

Private Households Industry

36th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 3.1 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

H. Lundbeck A/S (OTCMKTS:HLUYY) Frequently Asked Questions

Is H. Lundbeck A/S a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for H. Lundbeck A/S in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" H. Lundbeck A/S stock.
View analyst ratings for H. Lundbeck A/S
or view top-rated stocks.

What stocks does MarketBeat like better than H. Lundbeck A/S?

Wall Street analysts have given H. Lundbeck A/S a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but H. Lundbeck A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting H. Lundbeck A/S?

H. Lundbeck A/S saw a drop in short interest in May. As of May 14th, there was short interest totaling 200 shares, a drop of 66.7% from the April 29th total of 600 shares. Based on an average daily trading volume, of 3,700 shares, the short-interest ratio is currently 0.1 days.
View H. Lundbeck A/S's Short Interest

When is H. Lundbeck A/S's next earnings date?

H. Lundbeck A/S is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for H. Lundbeck A/S

How were H. Lundbeck A/S's earnings last quarter?

H. Lundbeck A/S (OTCMKTS:HLUYY) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.16. The firm had revenue of $547.05 million for the quarter, compared to the consensus estimate of $514.82 million. H. Lundbeck A/S had a net margin of 12.82% and a trailing twelve-month return on equity of 23.57%.
View H. Lundbeck A/S's earnings history

How has H. Lundbeck A/S's stock price been impacted by Coronavirus (COVID-19)?

H. Lundbeck A/S's stock was trading at $31.52 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HLUYY stock has decreased by 2.7% and is now trading at $30.67.
View which stocks have been most impacted by COVID-19

How often does H. Lundbeck A/S pay dividends? What is the dividend yield for H. Lundbeck A/S?

H. Lundbeck A/S announced an annual dividend on Thursday, February 4th. Shareholders of record on Thursday, March 25th will be given a dividend of $0.275 per share on Friday, April 2nd. This represents a yield of 0.68%. The ex-dividend date is Wednesday, March 24th.
View H. Lundbeck A/S's dividend history

Is H. Lundbeck A/S a good dividend stock?

H. Lundbeck A/S pays an annual dividend of $0.27 per share and currently has a dividend yield of 0.87%. The dividend payout ratio of H. Lundbeck A/S is 9.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, H. Lundbeck A/S will have a dividend payout ratio of 12.27% next year. This indicates that H. Lundbeck A/S will be able to sustain or increase its dividend.
View H. Lundbeck A/S's dividend history.

Who are H. Lundbeck A/S's key executives?

H. Lundbeck A/S's management team includes the following people:
  • Dr. Deborah Dunsire, Pres & CEO (Age 59, Pay $3.13M)
  • Mr. Anders Götzsche, Exec. VP & CFO (Age 54, Pay $1.46M)
  • Mr. Lars Bang, Exec. VP of Product Devel. & Supply (Age 59, Pay $1.16M)
  • Mr. Jacob Tolstrup, Exec. VP of Commercial Operations (Age 49, Pay $1.11M)
  • Dr. Per Johan Luthman, Exec. VP of R&D (Age 62, Pay $1.1M)
  • Dr. Tarek Samad, Sr. VP & Head of Research
  • Mr. Palle Holm Olesen, Chief Specialist & VP of Investor Relations
  • Juliane Lenzner, VP of Corp. Communication
  • Ms. Elise Hauge, Exec. VP and Head of People & Communication (Age 54)
  • Mr. Ole Chrintz, Sr. VP of International Markets (Age 63)

Who are some of H. Lundbeck A/S's key competitors?

What is H. Lundbeck A/S's stock symbol?

H. Lundbeck A/S trades on the OTCMKTS under the ticker symbol "HLUYY."

How do I buy shares of H. Lundbeck A/S?

Shares of HLUYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is H. Lundbeck A/S's stock price today?

One share of HLUYY stock can currently be purchased for approximately $30.67.

How much money does H. Lundbeck A/S make?

H. Lundbeck A/S has a market capitalization of $6.11 billion and generates $2.71 billion in revenue each year. The company earns $242.21 million in net income (profit) each year or $2.90 on an earnings per share basis.

How many employees does H. Lundbeck A/S have?

H. Lundbeck A/S employs 5,628 workers across the globe.

What is H. Lundbeck A/S's official website?

The official website for H. Lundbeck A/S is www.lundbeck.com.

Where are H. Lundbeck A/S's headquarters?

H. Lundbeck A/S is headquartered at Ottiliavej 9 Valby, Copenhagen G7, 2500.

How can I contact H. Lundbeck A/S?

H. Lundbeck A/S's mailing address is Ottiliavej 9 Valby, Copenhagen G7, 2500. The company can be reached via phone at 45-3630-1311 or via email at [email protected]

This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.